Medium materiality6/10
Iovance Biotherapeutics price target raised to $15 from $13 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises IOVAs target to $15 from $13; current price about $9.87.
- Target $15
- Posted price $9.87
- Analyst firm Barclays
Key facts
- 01
Target: $15
- 02
Posted price: $9.87
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.